Correlation of oncotype DX recurrence score with histologic grading and estrogen receptor positivity

被引:0
|
作者
Bhargava, Rohit [1 ]
Dabbs, David [1 ]
Brufsky, Adam [1 ]
Beriwal, Sushil [1 ]
机构
[1] Univ Pittsburgh, Med Ctr, Magee Womens Hosp, Pittsburgh, PA USA
关键词
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
24
引用
收藏
页码:8 / 9
页数:2
相关论文
共 50 条
  • [21] The Effect of Oncotype Dx® Recurrence Score on Treatment Recommendations for Patients with Early Stage Estrogen Receptor Positive Breast Cancer
    Acs, G.
    Esposito, N.
    Kiluk, J.
    Laronga, C.
    Lee, M. C.
    Loftus, L.
    Soliman, H.
    Boughey, J. C.
    Reynolds, C.
    Acs, P.
    Gordan, L.
    CANCER RESEARCH, 2009, 69 (24) : 726S - 726S
  • [22] Is there a role for the oncotype DX breast recurrence score genomic assay in estrogen receptor-low positive breast cancer?
    Giordano, Julia
    McGrath, Monica
    Harrison, Beth
    Kantor, Olga
    Vora, Halley
    Burstein, Harold J.
    Tolaney, Sara M.
    King, Tari A.
    Mittendorf, Elizabeth A.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [23] Estrogen Receptor β Isoforms 1, 2 and 5 and Oncotype Recurrence Score
    Fung, A.
    Adams, A.
    Page, A.
    Williams, D.
    Cohen, C.
    MODERN PATHOLOGY, 2010, 23 : 46A - 46A
  • [24] Histopathologic variables predict Oncotype DX™ Recurrence Score
    Flanagan, Melina B.
    Dabbs, David J.
    Brufsky, Adam M.
    Beriwal, Sushil
    Bhargava, Rohit
    MODERN PATHOLOGY, 2008, 21 (10) : 1255 - 1261
  • [25] Estrogen Receptor β Isoforms 1, 2 and 5 and Oncotype Recurrence Score
    Fung, A.
    Adams, A.
    Page, A.
    Williams, D.
    Cohen, C.
    LABORATORY INVESTIGATION, 2010, 90 : 46A - 46A
  • [26] Breast Cancer Histologic Grade and Histologic Subtype Impact Recurrence Score; Retrospective Review of 863 Oncotype Dx Results
    He, Xin
    Kalife, Elizabeth T.
    Ehdaivand, Shahrzad
    Wang, Yihong
    Sung, James C.
    Singh, Kamaljeet
    LABORATORY INVESTIGATION, 2017, 97 : 46A - 46A
  • [27] Breast Cancer Histologic Grade and Histologic Subtype Impact Recurrence Score; Retrospective Review of 863 Oncotype Dx Results
    He, Xin
    Kalife, Elizabeth T.
    Ehdaivand, Shahrzad
    Wang, Yihong
    Sung, James C.
    Singh, Kamaljeet
    MODERN PATHOLOGY, 2017, 30 : 46A - 46A
  • [28] Comparison of Magee and Oncotype DX Recurrence Scores in estrogen receptor positive breast cancers
    Walts, Ann E.
    Mirocha, James M.
    Bose, Shikha
    BREAST JOURNAL, 2018, 24 (06): : 951 - 956
  • [29] Comparison between the Nottingham Prognostic Index and Oncotype Dx Recurrence Score in Predicting Outcome in Estrogen Receptor Positive Breast Cancer
    Kerin, Eoin Patrick
    Davey, Matthew G.
    Malone, Carmel
    Barry, Michael K.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2023, 236 (05) : S5 - S6
  • [30] Treatment decisions in estrogen receptor-positive early breast cancer patients with intermediate oncotype DX recurrence score results
    Fried, Georgeta
    Moskovitz, Mor
    SPRINGERPLUS, 2014, 3 : 1 - 8